Blood Purification Equipment Market

Global Blood Purification Equipment Market By Product (Portable and Stationary), By Indication (Renal Diseases, Sepsis and Other Equipment), By End User (Dialysis Centers, Hospitals and Clinics and Other End Users), By Regional Outlook, Industry Analysis Report and Forecast, 2020 - 2026

Report Id: KBV-5665 Publication Date: April-2021 Number of Pages: 181
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Global Blood Purification Equipment Market size is expected to reach $19.2 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period.

Blood purification refers to a method that includes blood withdrawal from the body of a patient into a machine or a device to eliminate impurities and send it back into the body. The market is expected to be fueled as blood purification plays a crucial part in various kidney & blood-related diseases. Developments in filtration & dialysis methods along with adsorption methods have boosted the adoption of these machines in various critical treatments. Blood purification machines find considerable application in renal or organ failures, plasmapheresis & immune-metabolic disorders.

Technological developments in blood purification machines will impact the market growth positively during the forecast period. Leading market players plan to launch innovative & advanced blood purification equipment. For example, companies like Jafron and NxStage have created various blood purification devices that have decreased the mortality rate in patients experiencing chronic kidney failure. Newly approved blood purification machines are highly sensitive & allow exhaustive observation. Moreover, these sophisticated blood purification equipment is economical & portable. Therefore, the above-mentioned aspects would bolster the growth of the market in the next few years.

Blood Purification Equipment Market Size

Product Outlook

Based on Product, the market is segmented into Portable and Stationary. The portable blood purification equipment segment obtained the significant revenue share in 2019 and would maintain the same kind of trend in the next few years. Portable equipment is highly used by healthcare experts during the constant blood purification process. The portability of equipment enables effective treatment during emergency cases. Moreover, portable equipment is very compact & takes least space that further augments its adoption.

Blood Purification Equipment Market Share

Indication Outlook

Based on Indication, the market is segmented into Renal Diseases, Sepsis and Other Equipments. In 2019, the renal disease segment obtained the maximum revenue share and would emerge as a leading segment during the forecast period due to a surge in rates of renal disorders around the globe.

Blood Purification Equipment Market Report Coverage
Report Attribute Details
Market size value in 2019 USD 13.4 Billion
Market size forecast in 2026 USD 19.2 Billion
Base Year 2019
Historical Period 2016 to 2018
Forecast Period 2020 to 2026
Revenue Growth Rate CAGR of 5.3% from 2020 to 2026
Number of Pages 181
Number of Tables 340
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered Product, Indication, End User, Region
Country scope US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers
  • Emerging technologies and the development of innovative equipment are increasing
  • The increasing number of R&D activities
  • COVID-19 will negatively impact the market growth

Free Valuable Insights: Global Blood Purification Equipment Market to reach a market size of $19.2 Billion by 2026

End User Outlook

Based on End User, the market is segmented into Dialysis Centers, Hospitals and Clinics and Other End Users. The clinics segment would display a significant growth rate during the forecast period. Clinics are integrated with cutting-edge medical devices & equipment. Using blood purification services, clinics can provide speedier patient recovery as these clinics follow international regulations. The people who are currently going through renal failures are generally inclined towards blood purification from clinics that would fuel the growth of the global market.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North American blood purification equipment market would show major CAGR during the forecast years. The regional growth can be accredited to supportive demographic trends like the increasing geriatric population. A major segment of the geriatric population suffers from one or other types of chronic renal diseases that would act as a driver for the growth of the market. Moreover, the growth of the regional market would be propelled by favourable government regulations regarding blood purification equipment.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Corporation, Nikkiso Co., Ltd., Kaneka Corporation, Cerus Corporation, Shanwaishan Medical Group, Jafron Biomedical Co., Ltd., Infomed SA, and Fresenius SE & Co. KGaA.

Recent Strategies Deployed in Blood Purification Equipment Market

  • Mar-2021: B. Braun Avitum signed a co-marketing agreement with CytoSorbents Corporation, a critical care immunotherapy leader. The agreement was aimed to promote the use of CytoSorb with B. Braun's latest OMNI continuous blood purification platform and OMNIset Plus bloodline set (set version 3.0 or higher).
  • Jul-2020: Baxter India, a subsidiary of Baxter International got the Central Drugs Standard Control Organisation (CDSCO), India approval for its blood purification filter oXiris for the treatment of COVID-19 patients.
  • Apr-2020: Baxter International received emergency use authorization (EUA) from the U.S. FDA for its Oxiris filter set. This set is used for the treatment of the patients suffering from COVID-19 and have been admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure in need of blood purification therapy for reducing pro-inflammatory cytokine levels, including use in continuous renal replacement therapy (CRRT).
  • Feb-2020: Baxter International signed a distribution agreement with Spectral Medical Inc., a late stage theranostic company. The distribution agreement includes TORAYMYXIN PMX-20R (PMX), a hemoperfusion filter, and the Endotoxin Activity Assay (EAA), an on-market companion diagnostic tool that aids in the risk assessment of ICU patients for progression to severe sepsis.
  • Sep-2017: Baxter International introduced a new indication for the company’s oXiris set. This can now be used to help remove excessive levels of cytokines, endotoxin and other inflammatory mediators from a patient’s blood.

Scope of the Study

Market Segments Covered in the Report:

By Product

  • Portable
  • Stationary

By Indication

  • Renal Diseases
  • Sepsis
  • Other Equipments

By End User

  • Dialysis Centers
  • Hospitals and Clinics
  • Other End Users

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Asahi Kasei Corporation
  • Nikkiso Co., Ltd.
  • Kaneka Corporation
  • Cerus Corporation
  • Shanwaishan Medical Group
  • Jafron Biomedical Co., Ltd.
  • Infomed SA
  • Fresenius SE & Co. KGaA
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

Frequently Asked Questions About This Report

The global blood purification equipment market size is expected to reach $19.2 billion by 2026.

Emerging technologies and the development of innovative equipment are increasing are driving the market in coming years, however, COVID-19 will negatively impact the market growth have limited the growth of the market.

B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Corporation, Nikkiso Co., Ltd., Kaneka Corporation, Cerus Corporation, Shanwaishan Medical Group, Jafron Biomedical Co., Ltd., Infomed SA, and Fresenius SE & Co. KGaA.

The expected CAGR of the blood purification equipment market is 5.3% from 2020 to 2026.



Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo